Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Novartis company LenSx ® Laser Continuum of Innovation October 2012 LSX12184SK | October 2012 |

Similar presentations


Presentation on theme: "A Novartis company LenSx ® Laser Continuum of Innovation October 2012 LSX12184SK | October 2012 |"— Presentation transcript:

1 a Novartis company LenSx ® Laser Continuum of Innovation October 2012 LSX12184SK | October 2012 |

2 LSX12184SK – A I October 2012 LenSx ® Laser Important Safety Information Attention: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions. Warnings: The LenSx® Laser System should only be operated by a physician trained in its use. The LenSx® Laser delivery system employs one sterile disposable LenSx® Laser Patient Interface consisting of an applanation lens and suction ring. The Patient Interface is intended for single use only. The disposables used in conjunction with ALCON® instrument products constitute a complete surgical system. Use of disposables other than those manufactured by Alcon may affect system performance and create potential hazards. The physician should base patient selection criteria on professional experience, published literature, and educational courses. Adult patients should be scheduled to undergo cataract extraction. Precautions: Do not use cell phones or pagers of any kind in the same room as the LenSx® Laser. Discard used Patient Interfaces as medical waste. AEs/Complications: Capsulotomy, phacofragmentation, or cut or incision decentration Incomplete or interrupted capsulotomy, fragmentation, or corneal incision procedure Capsular tear Corneal abrasion or defect Pain Infection Bleeding Damage to intraocular structures Anterior chamber fluid leakage, anterior chamber collapse Elevated pressure to the eye Caution: United States Federal Law restricts this device to sale and use by or on the order of a physician or licensed eye care practitioner. Indication: The LenSx® Laser is indicated for use in patients undergoing cataract surgery for removal of the crystalline lens. Intended uses in cataract surgery include anterior capsulotomy, phacofragmentation, and the creation of single plane and multi-plane arc cuts/incisions in the cornea, each of which may be performed either individually or consecutively during the same procedure. Restrictions: Patients must be able to lie flat and motionless in a supine position. Patient must be able to understand and give an informed consent. Patients must be able to tolerate local or topical anesthesia. Patients with elevated IOP should use topical steroids only under close medical supervision. Contraindications: Corneal disease that precludes applanation of the cornea or transmission of laser light at 1030nm wavelength Descemetocele with impending corneal rupture Presence of blood or other material in the anterior chamber Poorly dilating pupil, such that the iris is not peripheral to the intended diameter for the capsulotomy Conditions which would cause inadequate clearance between the intended capsulotomy depth and the endothelium (applicable to capsulotomy only) Previous corneal incisions that might provide a potential space into which the gas produced by the procedure can escape Corneal thickness requirements that are beyond the range of the system Corneal opacity that would interfere with the laser beam Hypotony, glaucoma, or the presence of a corneal implant Residual, recurrent, active ocular or eyelid disease, including any corneal abnormality (for example, recurrent corneal erosion, severe basement membrane disease) This device is not intended for use in pediatric surgery A history of lens with zonular instability. Any contraindication to cataract or keratoplasty surgery.

3 LSX12184SK – A I October 2012 LenSx ® Laser: Continuum of Innovation Software Patient Interface (PI) Functionality Performance

4 LSX12184SK – A I October 2012 Continuum of Innovation: LenSx ® Laser 2012 Modified Patient Interface Narrower cone apex, easier docking 19.8 mm diameter Software 2.16: Precision, Automation & Flexibility HD OCT, 2x Resolution Advanced Automation Procedure pattern overlays Supports Bi-Manual technique Faster overall procedure Surgical Performance Improvement –Better capsulotomy and lens fragmentation

5 LSX12184SK – A I October 2012 Product Requirements The LenSx ® SoftFit™ Patient Interface Delivers: Lower IOP Easier docking Patient comfort Free floating capsulotomy in nearly all cases Pristine cut edges

6 LSX12184SK – A I October 2012 A Simple Solution Proprietary soft contact lens insert LenSx ® SoftFit™ Insert

7 LSX12184SK – A I October 2012 Current PI Design with extended suction skirt Proprietary soft contact lens insert Lower IOP – 16 mm Hg increase* Simple docking process – better eye control, no fogging Improved surgical performance* Alcon ® LenSx ® Laser SoftFit™ Patient Interface *LenSx® Laser Directions for Use

8 LSX12184SK – A I October 2012 New LenSx ® Laser SoftFit ™ Patient Interface: Reduces Corneal Compression & IOP to 16 mmHg Over Baseline

9 LSX12184SK – A I October 2012 NEW CAPSULOTOMY PERFORMANCE Insert Video

10 LSX12184SK – A I October 2012 New LenSx ® Laser SoftFit ™ Patient Interface Eliminates corneal compression Lowers IOP – 16mmHg increase Better visibility w/ no fogging Improves docking and centration Fixates cornea, no eye movement for precision incisions Dramatically improves surgical performance No liquid required……… Eliminates corneal compression in nearly all cases Lowers IOP – 16mmHg increase Better visibility w/ no fogging Improves docking and centration Fixates cornea, no eye movement for precision incisions Improved surgical performance No liquid required………

11 LSX12184SK – A I October 2012 LenSx ® Laser SoftFit ™ Patient Interface New Alcon ® LenSx ® Laser PI with proprietary soft contact lens technology allows the natural curvature of the cornea to conform to a soft contact lens insert delivering a gentle, secure fit with minimal corneal distortion. New PI retains all of the features of our single piece curved patient interface and provides additional benefits. –Easier docking –Lower IOP – 16 mmHg increase (over baseline) –Enhanced Patient comfort –Free floating capsulotomy in nearly all cases –Pristine capsulotomy edge

12 a Novartis company © 2012 Novartis 10-12 LSX12184SK-A


Download ppt "A Novartis company LenSx ® Laser Continuum of Innovation October 2012 LSX12184SK | October 2012 |"

Similar presentations


Ads by Google